Banagan, Baby Girl .

HRN: 26-00-11  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2024
AMPICILLIN 250MG (VIAL)
10/03/2024
10/10/2024
IV
160mg
Q12H
PSNB (Home Delivery)
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: